Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesRelapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis
Journal of Clinical Oncology, 06/12/09
Tomida S et al. - In a study to to identify a relapse-related signature that allows selection of a group of adenocarcinoma pts with a high probability of relapse, it was found that relapse-related molecular signature represented by 82 probes (RRS-82) may be useful for identifying adenocarcinoma pts at very high risk for relapse, even those with cancer in the early stage.
Methods- Whole-genome expression profiles were analyzed in 117 lung adenocarcinoma samples using microarrays consisting of 41,000 probes.
- A weighted voting classifier for identifying pts with a relapse-related signature was constructed with an approach that allowed no information leakage during each training step, using 10-fold cross-validation and 100 random partitioning procedures.
- RRS-82 was identified through genome-wide expression profiling analysis of a training set of 60 pts.
- The robustness of RRS-82 in the selection of pts with a high probability of relapse was then validated with a completely blinded test set of 27 adenocarcinoma pts, showing a clear association of high-risk RRS-82 with very poor pt prognosis regardless of disease stage.
- Discriminatory power of RRS-82 was further validated using 30 stage I pts who underwent surgery at a distinct period of time as well as with the Duke data set on a different platform.
- Completely separate training and validation procedures using another data set also successfully confirmed the predictive power of the genes comprising RRS-82.
Related Articles
A case of primary leptomeningeal gliomatosis confined to the spinal cord
Journal of Neuro-Oncology, 11/18/09
Relevance Score: 64%
Extremity soft tissue sarcomas presented as hematomas
Archives of Orthopaedic and Trauma Surgery, 10/23/09
Relevance Score: 62%
Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer–Specific Immune Responses and Their Correlation to Prognosis
Cancer Research, 11/03/09
Relevance Score: 43%
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
Annals of Oncology, 10/20/09
Relevance Score: 43%
A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma
Medical Oncology, 10/09/09
Relevance Score: 43%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status
Critical Reviews in Oncology/Hematology, 12/01/09
Pulmonary neuroendocrine neoplasms: A review of clinicopathologic and cytologic features
Diagnostic Cytopathology, 12/01/09
A rare case of pulmonary cryptococcal inflammatory myofibroblastic tumor diagnosed by fine needle aspiration cytology
Diagnostic Cytopathology, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor